Concepedia
Statistics
Publications
6
Citations
260
H-Index
Active since
1991
Affiliations
AGCO (United Kingdom)(Current)
Bloomfield College
Maya Gurnani is an author at AGCO (United Kingdom) specializing in oncology, medicine, and pharmacology.
Publications per year
1991–2000
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Loretta L. Nielsen, P Lipari, J Dell et al. · PubMed · 1998 · 125 citations
Medicine, Oncology, Pharmacology +13
Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
Loretta L. Nielsen, Carolyn Discafani, Maya Gurnani et al. · PubMed · 1991 · 51 citations
Medicine, Oncology, Pathology +17
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.
Loretta L. Nielsen, Bin Shi, Gerald Hajian et al. · PubMed · 1999 · 36 citations
In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background.
Loretta L. Nielsen, Maya Gurnani, Joseph J. Catino et al. · PubMed · 1995 · 18 citations
Medicine, Oncology, Pharmacology +17
Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs.
Loretta L. Nielsen, Maya Gurnani, Ronald D. Tyler · PubMed · 1992 · 17 citations
Medicine, Oncology, Pharmacology +15
1–5 of 6